Sentinel Trust Co. LBA lessened its position in shares of Cigna (NYSE:CI) by 36.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,090 shares of the health services provider’s stock after selling 9,803 shares during the quarter. Sentinel Trust Co. LBA’s holdings in Cigna were worth $3,471,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. grew its stake in shares of Cigna by 1.2% in the 4th quarter. BlackRock Inc. now owns 17,155,180 shares of the health services provider’s stock valued at $3,484,045,000 after purchasing an additional 206,718 shares during the last quarter. Ameriprise Financial Inc. grew its stake in shares of Cigna by 4.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 3,776,414 shares of the health services provider’s stock valued at $705,889,000 after purchasing an additional 171,712 shares during the last quarter. Sanders Capital LLC grew its stake in shares of Cigna by 1.8% in the 4th quarter. Sanders Capital LLC now owns 3,015,393 shares of the health services provider’s stock valued at $667,646,000 after purchasing an additional 52,400 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Cigna by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 2,419,889 shares of the health services provider’s stock valued at $490,343,000 after purchasing an additional 40,144 shares during the last quarter. Finally, Swedbank grew its stake in shares of Cigna by 9.0% in the 4th quarter. Swedbank now owns 1,936,346 shares of the health services provider’s stock valued at $393,253,000 after purchasing an additional 159,769 shares during the last quarter. Hedge funds and other institutional investors own 88.84% of the company’s stock.
In other news, EVP John M. Murabito sold 28,037 shares of the business’s stock in a transaction on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total value of $5,766,650.16. Following the completion of the transaction, the executive vice president now directly owns 60,290 shares of the company’s stock, valued at $12,400,447.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO David Cordani sold 36,769 shares of the business’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $191.68, for a total value of $7,047,881.92. Following the completion of the transaction, the chief executive officer now directly owns 372,076 shares of the company’s stock, valued at $71,319,527.68. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 86,103 shares of company stock valued at $17,217,951. 1.10% of the stock is currently owned by insiders.
Several research analysts have weighed in on the company. Barclays assumed coverage on Cigna in a research note on Thursday, March 8th. They issued an “overweight” rating and a $235.00 target price on the stock. Oppenheimer lifted their target price on Cigna to $237.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Zacks Investment Research cut Cigna from a “hold” rating to a “sell” rating in a report on Wednesday. Goldman Sachs initiated coverage on Cigna in a report on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 price target for the company. Finally, Credit Suisse Group reduced their price target on Cigna from $232.00 to $215.00 and set an “outperform” rating for the company in a report on Monday, March 12th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Cigna presently has an average rating of “Buy” and a consensus target price of $210.37.
CI stock traded down $1.21 during midday trading on Friday, hitting $167.82. 1,625,231 shares of the stock were exchanged, compared to its average volume of 3,864,306. The stock has a market cap of $41,053.23, a PE ratio of 16.04, a P/E/G ratio of 1.02 and a beta of 0.60. Cigna has a fifty-two week low of $149.10 and a fifty-two week high of $227.13. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.37 and a current ratio of 0.37.
Cigna (NYSE:CI) last issued its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.07. The firm had revenue of $10.53 billion during the quarter, compared to analysts’ expectations of $10.28 billion. Cigna had a return on equity of 18.84% and a net margin of 5.38%. Cigna’s revenue was up 5.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.87 earnings per share. equities research analysts predict that Cigna will post 12.9 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 10th. Investors of record on Monday, March 12th will be issued a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, March 9th. This represents a $0.16 annualized dividend and a yield of 0.10%. Cigna’s dividend payout ratio is presently 0.38%.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/08/cigna-co-ci-shares-sold-by-sentinel-trust-co-lba.html.
Cigna Company Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.